SUMMIT THERAPEUTICS LIMITED

Company number 05197494

Date	Type	Description	View / Download
03 Jan 2020	SH01	Statement of capital following an allotment of shares on 23 December 2019 GBP 1,605,118.31	(3 pages)
03 Jan 2020	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ Company business 23/12/2019 RES10 ‐ Resolution of allotment of securities	(3 pages)
24 Dec 2019	AP01	Appointment of Mr Manmeet Singh Soni as a director on 24 December 2019	(2 pages)
24 Dec 2019	AP01	Appointment of Dr Ventzislav Kirilov Stefanov as a director on 24 December 2019	(2 pages)
24 Dec 2019	AP01	Appointment of Dr Elaine Carla Stracker as a director on 24 December 2019	(2 pages)
24 Dec 2019	AP01	Appointment of Mr Robert William Duggan as a director on 24 December 2019	(2 pages)
24 Dec 2019	TM01	Termination of appointment of David Michael Wurzer as a director on 24 December 2019	(1 page)
24 Dec 2019	TM01	Termination of appointment of Frank Murdoch Armstrong as a director on 24 December 2019	(1 page)
24 Dec 2019	TM01	Termination of appointment of Leopoldo Zambeletti as a director on 24 December 2019	(1 page)
20 Dec 2019	AA01	Current accounting period shortened from 31 January 2020 to 31 December 2019	(1 page)
11 Oct 2019	TM01	Termination of appointment of Valerie Andrews as a director on 11 October 2019	(1 page)
04 Oct 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(1 page)
11 Jul 2019	CS01	Confirmation statement made on 30 June 2019 with no updates	(3 pages)
27 Jun 2019	AA	Group of companies' accounts made up to 31 January 2019	(120 pages)
01 May 2019	SH01	Statement of capital following an allotment of shares on 23 April 2019 GBP 1,604,947.58	(3 pages)
21 Feb 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ Waiver granted by panel of the obligations pursuant to rule 9 of the takeover code is approved 04/01/2019 RES10 ‐ Resolution of allotment of securities	(1 page)
18 Jan 2019	SH01	Statement of capital following an allotment of shares on 8 January 2019 GBP 1,603,898.81	(3 pages)
29 Nov 2018	CH01	Director's details changed for Mr Leopoldo Zambeletti on 29 November 2018	(2 pages)
29 Nov 2018	CH01	Director's details changed for Mr Frank Murdoch Armstrong on 29 November 2018	(2 pages)
01 Nov 2018	SH01	Statement of capital following an allotment of shares on 24 October 2018 GBP 822,648.81	(3 pages)
20 Sep 2018	TM01	Termination of appointment of Stephen Graham Davies as a director on 20 September 2018	(1 page)
20 Sep 2018	TM01	Termination of appointment of Barry John Price as a director on 20 September 2018	(1 page)
21 Aug 2018	RP04SH01	Second filing of a statement of capital following an allotment of shares on 4 October 2017 GBP 706,293.52	(7 pages)
21 Aug 2018	RP04SH01	Second filing of a statement of capital following an allotment of shares on 2 October 2017 GBP 705,410.32	(7 pages)
21 Aug 2018	RP04SH01	Second filing of a statement of capital following an allotment of shares on 29 September 2017 GBP 704,438.33	(7 pages)